Matthew J During

Matthew J During

Ohio State University - Columbus / United States
Medical and Health Sciences / Neuroscience
AD Scientific Index ID: 882829
person_outline Matthew J During's MOST POPULAR ARTICLES
1-) Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the LEAD (liraglutide effect and action in …M Nauck, A Frid, K Hermansen, NS Shah, T Tankova, IH Mitha, ...Diabetes care 32 (1), 84-90, 200915532009
2-) Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brainMG Kaplitt, P Leone, RJ Samulski, X Xiao, DW Pfaff, KL O\\\\\\\\\\\\\\\'Malley, ...Nature genetics 8 (2), 148-154, 199415491994
3-) Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\'s disease: an open label, phase I trialMG Kaplitt, A Feigin, C Tang, HL Fitzsimons, P Mattis, PA Lawlor, ...The Lancet 369 (9579), 2097-2105, 200712082007
4-) Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brainMJ During, DD SpencerThe lancet 341 (8861), 1607-1610, 199311091993
5-) VEGF links hippocampal activity with neurogenesis, learning and memoryL Cao, X Jiao, DS Zuzga, Y Liu, DM Fong, D Young, MJ DuringNature genetics 36 (8), 827-835, 200410472004